231 related articles for article (PubMed ID: 17899199)
1. Human-placenta-derived mesenchymal stem cells inhibit proliferation and function of allogeneic immune cells.
Li C; Zhang W; Jiang X; Mao N
Cell Tissue Res; 2007 Dec; 330(3):437-46. PubMed ID: 17899199
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation.
Li CD; Zhang WY; Li HL; Jiang XX; Zhang Y; Tang PH; Mao N
Cell Res; 2005 Jul; 15(7):539-47. PubMed ID: 16045817
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.
Kern S; Eichler H; Stoeve J; Klüter H; Bieback K
Stem Cells; 2006 May; 24(5):1294-301. PubMed ID: 16410387
[TBL] [Abstract][Full Text] [Related]
4. Characterization and gene transfer in mesenchymal stem cells derived from human umbilical-cord blood.
Lu FZ; Fujino M; Kitazawa Y; Uyama T; Hara Y; Funeshima N; Jiang JY; Umezawa A; Li XK
J Lab Clin Med; 2005 Nov; 146(5):271-8. PubMed ID: 16242526
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation.
Wang JF; Wang LJ; Wu YF; Xiang Y; Xie CG; Jia BB; Harrington J; McNiece IK
Haematologica; 2004 Jul; 89(7):837-44. PubMed ID: 15257936
[TBL] [Abstract][Full Text] [Related]
7. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells.
Miao Z; Jin J; Chen L; Zhu J; Huang W; Zhao J; Qian H; Zhang X
Cell Biol Int; 2006 Sep; 30(9):681-7. PubMed ID: 16870478
[TBL] [Abstract][Full Text] [Related]
8. Comparison of immunomodulatory effects of placenta mesenchymal stem cells with bone marrow and adipose mesenchymal stem cells.
Lee JM; Jung J; Lee HJ; Jeong SJ; Cho KJ; Hwang SG; Kim GJ
Int Immunopharmacol; 2012 Jun; 13(2):219-24. PubMed ID: 22487126
[TBL] [Abstract][Full Text] [Related]
9. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
10. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta.
In 't Anker PS; Scherjon SA; Kleijburg-van der Keur C; de Groot-Swings GM; Claas FH; Fibbe WE; Kanhai HH
Stem Cells; 2004; 22(7):1338-45. PubMed ID: 15579651
[TBL] [Abstract][Full Text] [Related]
11. Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells.
Zhang Y; Li C; Jiang X; Zhang S; Wu Y; Liu B; Tang P; Mao N
Exp Hematol; 2004 Jul; 32(7):657-64. PubMed ID: 15246162
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia.
Zhao ZG; Li WM; Chen ZC; You Y; Zou P
Immunol Invest; 2008; 37(7):726-39. PubMed ID: 18821219
[TBL] [Abstract][Full Text] [Related]
13. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood.
Bieback K; Kern S; Klüter H; Eichler H
Stem Cells; 2004; 22(4):625-34. PubMed ID: 15277708
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mesenchymal stem cells from human placenta and bone marrow.
Zhang Y; Li CD; Jiang XX; Li HL; Tang PH; Mao N
Chin Med J (Engl); 2004 Jun; 117(6):882-7. PubMed ID: 15198892
[TBL] [Abstract][Full Text] [Related]
15. Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease.
Yañez R; Lamana ML; García-Castro J; Colmenero I; Ramírez M; Bueren JA
Stem Cells; 2006 Nov; 24(11):2582-91. PubMed ID: 16873762
[TBL] [Abstract][Full Text] [Related]
16. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
Le Blanc K; Ringdén O
Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
[TBL] [Abstract][Full Text] [Related]
17. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
[TBL] [Abstract][Full Text] [Related]
18. Optimization of primary culture condition for mesenchymal stem cells derived from umbilical cord blood with factorial design.
Fan X; Liu T; Liu Y; Ma X; Cui Z
Biotechnol Prog; 2009; 25(2):499-507. PubMed ID: 19319963
[TBL] [Abstract][Full Text] [Related]
19. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood.
Gang EJ; Jeong JA; Hong SH; Hwang SH; Kim SW; Yang IH; Ahn C; Han H; Kim H
Stem Cells; 2004; 22(4):617-24. PubMed ID: 15277707
[TBL] [Abstract][Full Text] [Related]
20. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.
Rebelatto CK; Aguiar AM; Moretão MP; Senegaglia AC; Hansen P; Barchiki F; Oliveira J; Martins J; Kuligovski C; Mansur F; Christofis A; Amaral VF; Brofman PS; Goldenberg S; Nakao LS; Correa A
Exp Biol Med (Maywood); 2008 Jul; 233(7):901-13. PubMed ID: 18445775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
